What you missed at PSA21 Virtual – Day 2

Events
By
AP Staff
-

The second day of PSA’s annual conference kicked off with an inspirational keynote address from speed painter Sarah Rowan, who spoke about the need for creativity and blue sky thinking – all while producing an incredible piece of art. 

We are human beings, Ms Rowan told attendees at PSA21 Virtual, not human doings, and need to remember the importance of rest.

Next up were Australian Digital Health Agency CEO Amanda Cattermole and former PSA National President and CEO Dr Shane Jackson, who launched PSA’s new Digital Health Guidelines for Pharmacists. 

The guidelines will provide guidance on how to utilise digital health systems in a manner consistent with the code of ethics, professional practice standards and patient-centric care. They are designed to be practical resources for pharmacists in any area of practice – community, hospital, medicine review or multidisciplinary teams.

Continuing on the theme, PSA Senior Consulting Pharmacist Jarrod McMaugh MPS gave attendees an insight into best practice in digital health. Pharmacists have practiced ‘in the dark’ for too long, he said. Where a shared health record exists, pharmacists should access it every time it is clinically relevant to do so.

Other highlights included an excellent session on opioid use from Rawa Osman, Program Design Lead at NPS MedicineWise, who spoke about tailoring an individual’s pain management plan based on clinical guidelines.

Meanwhile, Dr Fei Sim FPS and Professor Lisa Nissen inspired attendees with their presentation on the opportunities for pharmacist prescribing and showed some brilliant results from the Urinary Tract Infection Prescribing Pilot, with more than 5,000 patients with uncomplicated UTI’s provided prescription-only treatment from pharmacists. The clear adherence to guidelines and positive patient feedback from the 1,200 pharmacists who have completed the training and are providing this service in Queensland clearly demonstrates prescribing is well and truly within a pharmacist’s scope of practice.

Earlier in the day, Associate Professor Suzanne Nielsen, Deputy Director of the Monash Addiction Research Centre, took the audience through pharmacist administration of depot buprenorphine, another area of practice where pharmacists are providing much needed collaborative service delivery.

Like what you’re reading? Don’t forget it’s not too late to register for Day 3 of PSA21 Virtual. 

PSA21 social pages 

Even more of the PSA21 Virtual tribe took part in the photo competition today, roping in friends, pets and children to get the perfect picture. Have you uploaded your photo with #PSA21Virtual to social media yet?

Here are some of our favourites from Day 2.

PSA21 Virtual final countdown

We’ve had a packed schedule of education sessions at PSA21 Virtual so far, and things aren’t slowing down for Day 3. 

The final day includes a session on pharmacy compliance (do you really need it?) at 9 am, naloxone for opioid toxicity (10.45 am), breaking barriers to emergency contraception (11.30 am) and supporting the quality use of injectables beyond vaccines (1.30 pm). 

There’s also lots of time to network during the engagement breaks, and to visit the virtual 3D exhibition. Don’t forget the PSA21 Virtual attendees with the most points at the end of the conference will receive some exciting prizes, and speaking to exhibitors is a great way to increase your score. 

Even if you haven’t managed to make it to PSA21 Virtual yet, you can still register here. This will give you access to the recorded education sessions on-demand for up to 2 years after the event ends, plus Monday Masterclasses during August.